Introduction {#s1}
============

Vertebrate bones develop via two largely distinct processes. Intramembranous (i.e. dermal) bone, which makes up a large portion of the skull, arises through the direct differentiation of mesenchymal precursors into osteoblasts and then osteocytes. In contrast, endochondral bone, which comprises the majority of the axial and limb skeletons, arises through the progressive remodeling of an embryonic cartilage template. On the outside of developing endochondral bone, perichondral cells mature into periosteal progenitors that contribute to the bone collar. The cartilage templates of endochondral bone are organized into distinct zones of chondrocytes: resting, proliferative, pre-hypertrophic, and hypertrophic. In mammals, chondrocytes at the edge of the developing hypertrophic zone largely disappear as the cartilage matrix is degraded, a process concurrent with the invasion of blood vessels, hematopoietic cells, and progenitors for osteoblasts and marrow adipocytes ([@bib24]). This growth plate remodeling contributes to the establishment of trabecular bone, complementing the cortical bone largely derived from the periosteum, and the marrow cavity supports continued hematopoiesis. As with mammals, zebrafish also have intramembranous and endochondral bones. Their endochondral bones are hollow and filled predominantly with fat yet do not support hematopoiesis as in mammals ([@bib41]; [@bib40]). It has remained unclear, however, whether zebrafish bone arises solely through osteoblast differentiation in the periosteum, or also through invasion of the vasculature and conversion of growth plate cartilage to bone as in mammals. The source of marrow adipocytes also remains unclear in either fish or mammals.

It has long been appreciated that many hypertrophic chondrocytes undergo cell death during endochondral ossification, with osteoblasts forming from periosteal cells brought into the bone along with the vasculature ([@bib24]). At the same time, there are numerous studies showing that cultured chondrocytes can dedifferentiate into mesenchymal progenitors and/or transdifferentiate into osteoblasts ([@bib36]; [@bib25]; [@bib38]). Recent lineage tracing studies of hypertrophic chondrocytes, using constitutive and inducible *Col10a1-Cre-* and *Aggrecan-Cre*-based transgenes in mice, has revealed that such transdifferentiation may also occur in vivo, with chondrocytes making a major contribution to osteoblasts within trabecular bone and potentially also the bone collar ([@bib42]; [@bib21]; [@bib17]; [@bib33]). A limitation of these studies is the use of population-based labeling by Cre recombination, which cannot exclude low-level and/or leaky labeling of other cell types. It is also unclear whether hypertrophic chondrocytes can give rise to other cell types, such as marrow adipocytes, and whether hypertrophic chondrocytes directly transform into osteoblasts or do so through a stem cell intermediate. Finally, it is unknown whether the ability of chondrocytes to generate osteoblasts and other cell types is specific to mammals or a more broadly shared feature of vertebrates.

In this study, we address the long-term fate of growth plate chondrocytes in zebrafish, as well as potential mechanisms of their fate plasticity. We use the ceratohyal (Ch) bone of the lower face as a model. This long bone, which is derived from cranial neural crest cells, exhibits properties in common with the long bones of mammalian limbs, including two prominent growth plates at either end and a marrow cavity ([@bib34]). Here, we describe remodeling of the Ch from a cartilage template to a fat-filled bone in juvenile stages, which coincides with extensive vascularization. Using inducible Cre and long-lived histone-mCherry fusion proteins, driven by regulatory regions of the chondrocyte genes *sox10* and *col2a1a*, we reveal contribution of chondrocytes to osteoblasts, adipocytes, and mesenchymal cells within the adult Ch. In mouse, *LepR* expression marks bone marrow cells that contribute to osteoblasts and adipocytes primarily after birth ([@bib44]). In zebrafish, we find that growth plate chondrocytes express *lepr* and re-enter the cell cycle during the late hypertrophic phase, raising the possibility that *Lepr* +skeletal stem cells may derive from growth plate chondrocytes. Further, we find that delayed remodeling of the hypertrophic cartilage zone in zebrafish *mmp9* mutants correlates with a paucity of marrow adipocytes. Unlike in mouse where Mmp9 functions in hematopoietic cells for timely growth plate remodeling ([@bib39]), we find that Mmp9 is sufficient in neural crest-derived chondrocytes of zebrafish for growth plate remodeling. Our studies reveal that growth plate chondrocytes generate osteocytes and adipocytes in zebrafish bones, potentially by transitioning through a proliferative intermediate.

Results {#s2}
=======

Remodeling of the Ch bone in juvenile zebrafish {#s2-1}
-----------------------------------------------

In order to characterize the progressive remodeling of an endochondral bone in zebrafish, we performed pentachrome staining on sections of the Ch bone from juvenile through adult stages ([Figure 1](#fig1){ref-type="fig"}). The Ch bone is shaped like a flattened barbell, and here we sectioned it to reveal the thin plane of the bone (see [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}) for a view along the thicker perpendicular plane). Unlike the unidirectional growth plates in the mouse limb, the two growth plates of Ch are bidirectional with a central zone of compact, proliferative chondrocytes flanked by hypertrophic chondrocytes on either side ([@bib34]). Unlike in many other fish species, the Ch bone, as with other bones in zebrafish, also contains embedded osteocytes ([@bib41]). At 11 mm standard length (SL) (approx. 4.5 weeks post-fertilization (wpf)), the Ch contains chondrocytes throughout its length with the exception of a small marrow space at the anterior tip. The Ch is surrounded by a thin layer of cortical bone that has been shown to derive from osteoblasts located on the outside of the cartilage template (i.e. periosteum) ([@bib34]). By 12 mm SL (approx. five wpf), both tips of the Ch contain marrow spaces, and on the central sides of the growth plates we begin to observe small fissures in the cortical bone and disruption of the hypertrophic zone. By 13 mm SL (approx. 5.5 wpf), breaks in the cortical bone become more prominent and are accompanied by further degradation of the cartilage matrix. At later stages (16 and 19 mm SL) (approx. 7 and 9 wpf), cortical bone regains integrity and increases in thickness, and marrow adipocytes containing LipidTOX +lipid vesicles are seen throughout Ch ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). By adulthood (one year of age), the marrow cavity is filled with large fat cells and the growth plates appear largely mineralized. While we focus on the Ch for this study, a number of other cartilage-derived bones in the face and fins have been reported to have a similar structure in zebrafish, including growth plates and prominent marrow fat ([@bib40]).

![Time-course of Ch remodeling in juvenile zebrafish.\
(**A**) Pentachrome staining of a longitudinal section through the head of a 19 mm fish. The jaw is toward the left (anterior) and the gills toward the right (posterior). The green stain highlights the collagen matrix of cartilage, and the reddish-brown stain the mineralized matrix of bone. The bilateral set of Ch bones is indicated.* n* = 3. (**B**) High magnification views of the Ch at successive stages show the gradual replacement of chondrocytes in the central shaft and at each end with adipocytes (which appear white due to loss of lipid during processing). *n* = 3 for each stage. (**C**) Higher magnification views of the boxed regions in (**B**). Cortical bone appears reddish-brown. Note the breaks in cortical bone toward the lower part of the images at 12 and 13 mm, which are largely resolved by 16 and 19 mm. Scale bars = 50 μM.](elife-42736-fig1){#fig1}

Vascularization of the Ch bone in juvenile zebrafish {#s2-2}
----------------------------------------------------

Given the transient breakdown of cortical bone, we examined whether this coincides with vascularization of Ch. To do so, we performed confocal imaging of the dissected Ch from fish carrying both a chondrocyte-specific *col2a1a*:mCherry-NTR transgene and *fli1a*:GFP ([Figure 2A](#fig2){ref-type="fig"}). We used *fli1a*:GFP to label endothelial cells of the vasculature, but we also noticed that presumptive resting chondrocytes in the middle of the growth plate express this transgene. At 10 and 11 mm SL, vessels expressing *fli1a*:GFP are found largely on the outside of the Ch bone. By 13, 16, and 20 mm SL, we observe increasing numbers of capillaries within the Ch, coinciding with the replacement of *col2a1a*:mCherry-NTR +chondrocytes with adipocytes. High-magnification confocal sections at 18 mm SL clearly show *fli1a*:GFP+ vessels in intimate association with adipocytes and within the Calcein Blue+ bone collar ([Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}). Given the more complicated expression pattern of *fli1a*:GFP, we also independently confirmed blood vessel identity with *kdrl*:GFP. At 28 mm SL (approx. 26 wpf), the Ch is heavily supplied with both *kdrl*:GFP+blood vessels and *lyve1*:DsRed+lymphatic vessels, which abut each side of the growth plate ([Figure 2B](#fig2){ref-type="fig"}). Hence, as in mammalian bones, remodeling of the Ch bone is accompanied by extensive vascular invasion of the cartilage template.

![Vascularization of the Ch.\
(**A**) Confocal projections of dissected Ch bones at five successive stages. Merged fluorescent and brightfield channels show the gradual replacement of the cartilage with a fat-filled core.* col2a1a*:mCherry-NTR highlights chondrocytes that become increasingly restricted to two growth plates (GP) at either end of the bone. *fli1a*:GFP labels endothelial cells and chondrocytes located in the central portions of the growth plates. Vascularization of the Ch increases over time. *n* = 2 at each stage. (**B**) Confocal projection shows networks of *kdrl*:GFP+ vascular endothelial and *lyve1*:DsRed+ lymphatic endothelial cells within an adult Ch bone. The inset shows a single confocal section through the boxed portion of the growth plate, with both blood and lymphatic vessels abutting the edges but not penetrating into the growth plate. *n* = 2. Scale bars = 100 μm (**A**) and 200 μm (**B**).](elife-42736-fig2){#fig2}

Contribution of *sox10*-lineage cells to osteoblasts, adipocytes, and mesenchymal cells {#s2-3}
---------------------------------------------------------------------------------------

Given the extensive remodeling and vascularization of Ch, we next investigated the long-term fate of growth plate chondrocytes by multiple, independent methods. First, we constructed an inducible *sox10*:CreERT2 line and crossed it to a ubiquitous *bactin2*:loxP-tagBFP-stop-loxP-DsRed reporter (Blue to Red conversion: *B \> R*). The zebrafish *sox10* promoter drives expression in early cranial neural crest cells from 10 to 16 hpf, followed by a second wave of expression in all chondrocytes from two dpf onwards ([@bib8]). Here, we took advantage of this second wave of expression to label developmental chondrocytes. Upon addition of 4-hydroxytamoxifen (4-OHT) at 15 dpf, we observed extensive labeling of chondrocytes within 5 days, as well as some cells in the perichondrium surrounding Ch and other cartilages ([Figure 3A](#fig3){ref-type="fig"}). We did not observe leaky conversion in the absence of 4-OHT at either embryonic or adult stages ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). We then converted *sox10/B \> R* fish by 4-OHT treatment at 14 dpf and raised these to adulthood (27 mm SL) for analysis, with inclusion of an *ocn*:GFP transgene allowing us to label osteoblasts ([Figure 3B](#fig3){ref-type="fig"}). Confocal maximum intensity projections through Ch revealed extensive labeling of growth plate chondrocytes. We also observed numerous cells throughout the Ch, including in and around the marrow cavity. In sections through the middle of Ch, we observed labeling of a number of large diameter cells of adipocyte morphology ([Figure 3C](#fig3){ref-type="fig"}). In superficial sections through the cortical bone, we also observed labeled cells that were positive for the osteoblast marker *ocn*:GFP, as well as some labeled cells negative for *ocn*:GFP that may represent bone progenitors or other cell types ([Figure 3D](#fig3){ref-type="fig"}). As a comparison, we used a constitutive Cre driven by a human *SOX10* enhancer that drives expression throughout the neural crest lineage (note that this human enhancer lacks the second wave of chondrocyte expression seen with the zebrafish regulatory region used for the *sox10*:CreERT2 line) ([@bib18]). When crossed to the *B \> R* line, this neural crest-specific *SOX10*:Cre line drives broader conversion in the five dpf head than the later conversion of *sox10*:CreERT2 ([Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}). Analysis of the adult Ch in *SOX10*:Cre fish shows labeling of all growth plate cartilage, as well as most if not all adipocytes and numerous smaller cells throughout the marrow and cortical bone surface ([Figure 3---figure supplement 2B,C](#fig3s2){ref-type="fig"}). This is consistent with previous studies showing that the Ch bone is neural crest-derived ([@bib35]). However, we also detect unconverted cells in the marrow, consistent with contribution of non-neural crest-derived cells such as the mesoderm-derived vasculature ([Figure 2](#fig2){ref-type="fig"}).

![Contribution of *sox10*+ chondrocytes to osteoblasts and marrow adipocytes.\
(**A**) Confocal projection of a *sox10*:CreERT2; *bactin2*:tagBFP\>DsRed animal treated at 15 dpf with 4-OHT and imaged at 20 dpf. A ventral view of the lower face shows conversion in growth plate (GP) Ch chondrocytes, as well as additional mesenchymal cells throughout the face. *n* = 3. (**B**) Confocal projection of a dissected Ch bone from a *sox10*:CreERT2; *bactin2*:tagBFP\>DsRed; *ocn*:GFP animal converted at 14 dpf and imaged as an adult (27 mm SL). In addition to labeling of the growth plates, extensive DsRed+ cells are seen throughout the Ch in 3/3 strongly converted animals. (**C**) Higher magnification confocal section through the boxed region in (**B**) shows a subset of adipocytes labeled by DsRed (red, arrowheads). (**D**) Higher magnification confocal section through the boxed region in (**B**) shows a mixture of converted (yellow, arrowheads) and unconverted (green) *ocn*:GFP + osteoblasts, as well as converted *ocn*:GFP- mesenchymal cells (red, arrows). (**E**) Confocal projection of a dissected Ch bone from a *sox10*:CreERT2; *bactin2*:tagBFP \>DsRed animal converted at 14 dpf and imaged as an adult (30 mm SL). Three prominent clones in the growth plate are numbered. In the boxed regions to the right, a discrete clone of growth plate chondrocytes transitions into a stream of mesenchymal cells and then a number of adipocytes (arrowheads). The brightfield image from the same sample (below) shows the lipid vesicles characteristic of adipocytes. Similar clonal contributions were seen in four independently converted animals. (**F**) Confocal projection of a portion of a dissected Ch growth plate from a *sox10*:CreERT2; Zebrabow animal converted at 14 dpf and imaged as an adult (23 mm SL). Images are shown with and without the Nomarski channel. Unconverted cells are red, and distinctly colored growth plate clones are visible. Magnified images corresponding to the boxed regions are shown without the red channel to highlight distinct green and teal clones (brackets). The teal clone of growth plate chondrocytes is contiguous with two similarly colored adipocytes (Ad1, Ad2), and the green clone is contiguous with faintly green cells (arrowheads) in cortical bone. In the adipocyte clone, the arrow indicates a green marrow cell distinct from the teal-colored adipocytes. Comparable clonal contributions were seen in three independently converted animals. Scale bars = 100 μm (**A**), 200 μm (**B,E,F**), 50 μm (**C**).](elife-42736-fig3){#fig3}

As *sox10*:CreERT2-mediated conversion at 14 dpf also labels cells outside the cartilage, which could also contribute to osteoblasts and adipocytes, we next examined animals with lower conversion efficiency to follow discrete growth plate clones. When analyzed at 30 mm SL, growth plate clones could be quite large, consistent with clonal selection as described in the zebrafish heart and skeletal muscle ([@bib10]; [@bib28]). In one example with three discrete clones, we observed a clone that contributed to a narrow column of growth plate chondrocytes in the middle of Ch that was contiguous with mesenchymal cells and then adipocytes toward the central marrow cavity ([Figure 3E](#fig3){ref-type="fig"}). To more definitively follow growth plate clones, we also examined *sox10*:CreERT2; *ubb*:Zebrabow fish in which 4OH-T treatment at 14 dpf resulted in conversion of RFP (red) to various color combinations of CFP, YFP, and RFP at 23 mm SL. Analysis of uniquely colored clones in the growth plate revealed those that contained both chondrocytes and adjacent adipocytes in the marrow ([Figure 3F](#fig3){ref-type="fig"}). We also observed clones that appeared to contain chondrocytes and weakly labeled cells embedded in cortical bone, though the clonal contribution to these and other mesenchymal lineages will require further analysis. Together, our data are consistent with chondrocytes giving rise to adipocytes and mesenchymal cells, and potentially osteoblasts, after growth plate remodeling in zebrafish.

Contribution of *col2a1a*+ chondrocytes to osteoblasts, adipocytes, and mesenchymal cells {#s2-4}
-----------------------------------------------------------------------------------------

As *sox10*-CreERT2-mediated conversion was broader than just the cartilage, we also generated an inducible *col2a1a*-CreERT2 line to more precisely trace chondrocytes and their derivatives. In mice, *Col2a1*:CreERT2-mediated conversion at embryonic and early postnatal stages broadly labels not only chondrocytes but also osteochondroprogenitors, such as those in the perichondrium and periosteum ([@bib30]). In zebrafish, *col2a1a* is similarly expressed at high levels in chondrocytes and in weaker levels in osteoblasts and perichondrium, although direct evidence for *col2a1a* marking osteochondroprogenitors in zebrafish is lacking ([@bib9]). In order to restrict expression to chondrocytes, thus avoiding potential complications of labeling osteoblasts and putative perichondral progenitors, we utilized a chondrocyte-specific 'R2' enhancer of the zebrafish *col2a1a* gene that we had previously characterized ([@bib4]; [@bib1]). Treatment of *col2a1a/B \> R* fish with a single dose of 4-OHT at five dpf resulted in extensive labeling of *col2a1a-BAC*:GFP+ chondrocytes at 12 dpf, but no labeling of the perichondrium, periosteum, and osteoblasts as marked by the *sp7*:GFP transgene ([Figure 4A,B](#fig4){ref-type="fig"}; [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}). We also observed labeling of the notochord in larval fish, but no labeling of the vasculature, blood, or other tissues examined. After conversion of *col2a1a/B \> R* chondrocytes at five dpf and examination at adulthood (30 mm SL), maximal intensity projections through Ch revealed extensive labeling of growth plate chondrocytes, as well as cells throughout the bone and marrow cavity ([Figure 4C](#fig4){ref-type="fig"}). Thus, the majority of adult growth plate chondrocytes in Ch appear to derive from embryonic chondrocytes. Moreover, optical sections revealed cytoplasmic DsRed staining in lipid-filled adipocytes, presumptive osteoblasts lining the inner surface of bone, and mesenchymal cells within the marrow cavity. In some animals displaying lower conversion efficiency, we observed apparent clones of cells containing growth plate chondrocytes, large adipocytes, and osteoblasts embedded in Calcein +mineralized matrix ([Figure 4D](#fig4){ref-type="fig"}). Analysis of individual sections at higher magnification revealed contribution of *col2a1a*-lineage cells to a subset of osteoblasts within both the endosteal and periosteal surfaces of bone, as well as embedded osteocytes with characteristic cellular processes ([Figure 4E--G](#fig4){ref-type="fig"}).

![Contribution of *col2a1a*+ chondrocytes to osteoblasts and marrow adipocytes.\
(**A, B**) Ventral views of *col2a1a*:CreERT2; *bactin2*:tagBFP \>DsRed animals treated at 5 dpf with 4-OHT and imaged at 12 dpf. Confocal sections and projections as indicated demonstrate specific conversion (red) throughout cartilage, as shown by co-localization with the chondrocyte-specific marker *col2a1a-BAC*:GFP (**A**) and lack of co-localization with the osteoblast and periosteum marker *sp7*:GFP (**B**). Boxed areas are magnified in the top right insets. *n* = 6 for each. (**C**) After conversion of *col2a1a*:CreERT2; *bactin2*:tagBFP\>DsRed animals at five dpf, a confocal projection through the dissected Ch of an adult (30 mm SL) shows extensive DsRed+ cells in the growth plates (GP) and throughout the bone. A higher magnification view of the boxed region, along with brightfield, shows DsRed fluorescence in the thin cytoplasm surrounding the prominent lipid vesicles indicative of marrow adipocytes, as well as in osteoblasts (osteo) of cortical bone and mesenchymal cells (mes) within the marrow cavity. The dashed line in the *x-y* slice shows the position of the *x-z* slice above. *n* = 10. (**D**) In this example of a *col2a1a*:CreERT2; *bactin2*:tagBFP\>DsRed animal converted at five dpf and imaged as an adult, a prominent clone of DsRed+ cells are evident at the bottom of the growth plate, consisting of GP chondrocytes, adipocytes (Ac), and osteoblasts (Ob) associated with Calcein Green+ cortical bone. Similar clonal contributions were seen in four independently converted animals. (**E**) Pentachrome staining of a portion of the Ch growth plate at 19 mm SL shows the endosteum and periosteum. Note that zebrafish have osteocytes embedded in their cortical bone (the dark nuclei in the reddish-brown matrix). (**F, G**) High-magnification images of a section of Ch cortical bone from an animal converted at five dpf and imaged at 28 mm SL. DsRed+ osteoblasts/osteocytes are seen in the endosteal surface (arrows), periosteal surface (arrowheads), and embedded in bone (double arrowhead). The merged brightfield and fluorescence image from a different example (**G**) shows a DsRed+ cell with cellular processes characteristic of osteocytes. Scale bars = 100 μm (**A,B**), 200 μm (**C,D**), 50 μm (**F**), 20 μm (**G**).](elife-42736-fig4){#fig4}

Long-lived Histone2A-mCherry protein reveals contribution of *col2a1a*+ chondrocytes to osteoblasts {#s2-5}
---------------------------------------------------------------------------------------------------

A limitation of CreER-mediated lineage tracing is that it can be difficult to rule out contributions from rare converted cells outside the population of interest, for example in the perichondrium and periosteum. We therefore employed a Cre-independent approach to independently assess the fate of growth plate chondrocytes. To do so, we expressed a Histone2A-mCherry fusion protein in *col2a1a*+ cells. An advantage of this type of lineage approach is that the levels of Histone2A-mCherry protein, which is stably incorporated into chromatin, reflect those of endogenous *col2a1a* in chondrocytes provided continued cell division does not dilute out the fusion protein. This is in contrast to Cre-mediated approaches in which a strong ubiquitous promoter determines the level of a reporter protein; hence, even low levels of Cre recombinase activity outside of chondrocytes (e.g. in osteochondroprogenitors) can result in strong reporter expression. In zebrafish, *col2a1a* is expressed at high levels in the proliferative zone of the Ch growth plate and then downregulated in the hypertrophic zone ([@bib34]). In a newly generated *col2a1a*:Histone2A-mCherry-T2A-GFP-CAAX transgenic line, membrane-localized GFP-CAAX, which is rapidly turned over, is seen primarily in the proliferative zone, whereas Histone2A-mCherry is seen uniformly throughout the Ch cartilage, confirming the long-lived nature of this fusion protein ([Figure 5A](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1A,B](#fig5s1){ref-type="fig"}). At 7--8 mm SL (approx. three wpf), which is well before the start of growth plate remodeling at 11--12 mm SL, all Ch chondrocytes are Histone2A-mCherry+ and we do not detect Histone2A-mCherry+ cells associated with Calcein Blue+ bone or co-expressing the osteoblast transgene *ocn*:GFP ([Figure 5A](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1C,D](#fig5s1){ref-type="fig"}). In contrast, at post-remodeling stages (12 and 18 mm SL), we observe extensive overlap of Histone2A-mCherry with *ocn*:GFP+ osteoblasts associated with cortical bone ([Figure 5B](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1E](#fig5s1){ref-type="fig"}). We also observe numerous Histone2A-mCherry+ cells embedded in the endosteal and periosteal surfaces of the Ch bone (labeled by Calcein Blue), with several of these cells co-expressing the pre-osteoblast transgene *RUNX2*:GFP or the early osteoblast transgene *sp7*:GFP ([Figure 5C--E](#fig5){ref-type="fig"}). Note that *ocn*:GFP, *RUNX2*:GFP, and *sp7*:GFP can all be readily distinguished from membrane GFP-CAAX by their much stronger and cytoplasmic expression. In addition, we observed that *sp7*:GFP+ osteoblasts further from the growth plate tended to have weaker Histone2A-mCherry signal than those more closely associated with the edge of the hypertrophic zone, suggesting that hypertrophic chondrocytes and/or their osteoblast derivatives undergo cell division to dilute out the Histone2A-mCherry signal. These findings independently confirm the conclusions of our CreER lineage tracing studies that *col2a1a*+ chondrocytes generate osteoblasts in zebrafish.

![Tracing of *col2a1a*-lineage cells by a long-lived Histone2A-mCherry fusion protein.\
(**A**) At a stage preceding growth plate remodeling (8 mm SL), *col2a1a*:H2A-mCherry-2A-GFPCAAX labels chondrocytes, but not osteoblasts associated with Calcein Blue+ mineralized bone.rowth plate (GP) chondrocytes co-express the nuclear Histone2A-mCherry protein (red) and the membrane-localized GFPCAAX protein (green). In the middle and poles of Ch, hypertrophic chondrocytes retain the long-lived H2A-mCherry protein but not the short-lived GFPCAAX protein, reflective of the down-regulation of *col2a1a* expression during hypertrophic maturation. *n* = 3. (**B**) In a confocal section through the dissected Ch of a juvenile fish (18 mm SL), numerous H2A-mCherry+; *ocn*:GFP+ cells are seen in regions where the cartilage template is being converted to fat. Magnification of the boxed region shows the brightfield image (white), a merged image of H2A-mCherry+ cells (red) and *ocn*:GFP+ cells (green), and individual channels below. We observed a number of H2A-mCherry+; *ocn*:GFP+ cells (arrowheads) in 4/4 animals. (**C**) Confocal projection of a dissected Ch at 18 mm SL reveals cells expressing nuclear Histone2A-mCherry (red) on both the endosteal surface (arrows) and periosteal surface (arrowheads) of Calcein Blue+ cortical bone. Some H2A-mCherry+ cells associated with bone also co-express the osteoprogenitor marker *RUNX2*:GFP (yellow arrow). Note that the membrane GFPCAAX signal from the *col2a1a*:H2A-mCherry-2A-GFPCAAX transgene is much weaker and barely detectable in the proliferative zone at the gain settings used to image cytoplasmic *RUNX2*:GFP. *n* = 3. (**D**) Confocal section through the Ch at higher magnification shows several H2A-mCherry+; *RUNX2*:GFP+ cells (yellow arrows) in the marrow cavity and close to the endosteal surface of the Calcein Blue+ bone. (**E**) In adult fish (26 mm SL), several H2A-mCherry+ cells are found to co-express the osteoblast marker *sp7*:GFP on the endosteal surface. H2A-mCherry tends to be stronger closer to the growth plate; arrowheads denote stronger and arrows denote weaker H2A-mCherry signal. The white dotted line in the *x-y* section shows the location of the *x-z* section above. *n* = 5. Scale bars = 50 μm (**A,D,E**), 100 μm (**B,C**).](elife-42736-fig5){#fig5}

Hypertrophic chondrocytes re-enter the cell cycle and express *lepr* {#s2-6}
--------------------------------------------------------------------

The conversion of hypertrophic chondrocytes to osteoblasts and adipocytes could occur in the absence of cell division (i.e. 'transdifferentiation') and/or through partial dedifferentiation into a proliferative progenitor. To test these possibilities, we first used incorporation of bromodeoxyuridine (BrdU) to detect proliferative cells in the Ch during remodeling stages ([Figure 6A,B](#fig6){ref-type="fig"}). At the beginning of remodeling (11 mm SL), we detected BrdU+ cells in the central zone of chondroblasts in the growth plate, as well as in the perichondrium and periosteum. In addition, we observed BrdU+ cells at the edge of the hypertrophic zone where the cartilage matrix is being actively degraded, similar to what has been reported in mouse ([@bib33]). We observed BrdU incorporation in similarly positioned hypertrophic chondrocytes at 15 and 19 mm SL, with BrdU+ cells becoming fewer in the perichondrium and periosteum by 19 mm.

![Late-stage hypertrophic chondrocytes re-enter the cell cycle and express *lepr.*\
(**A**) Pentachrome staining of a section through a Ch growth plate at 14 mm SL. Arrowheads denote two examples of hypertrophic chondrocytes at the edges of the growth plates that lack collagen-rich matrix (green) and appear to be exiting their lacunae. (**B**) BrdU incorporation (pink) relative to all nuclei (Hoechst, blue) shows recently divided cells. Fluorescent images with or without brightfield are shown for 11 and 15 mm SL stages, and fluorescent channel only for 19 mm SL. In addition to BrdU +cells in the proliferative zones of the growth plates (brackets) and perichondrium (arrows), a subset of hypertrophic chondrocytes at the edges of the growth plates (arrowheads) are BrdU+ at each stage. Proliferative hypertrophic chondrocytes were seen in sections from three independent animals at each stage. (**C--D**) Fluorescent RNAscope in situ hybridization for *lepr* (green) and the hypertrophic chondrocyte and osteoblast precursor marker *runx2b* (white). Red signal indicates cells derived from *col2a1a/B \> R* chondrocytes that were converted by addition of 4-OHT at five dpf (detected by anti-DsRed antibody), and all nuclei are shown in blue (Hoechst). In a section of a Ch growth plate at 15 mm SL, the merged channel above and red/green and red/white channels below show expression of *lepr* and *runx2b* in chondrocytes and their derivatives. In the higher magnification view of the boxed region (**D**), *lepr* is expressed in proliferative chondrocytes, *runx2b* is expressed at high levels and *lepr* at lower levels in early hypertrophic chondrocytes, and *lepr* and *runx2b* are co-expressed in late hypertrophic chondrocytes and adjacent mesenchymal cells that have been released from the growth plate. Similar expression of *lepr* and *runx2b* was seen in sections from 4/4 independent animals. Scale bars = 50 μm (**B,C**), 20 μm (**D**).](elife-42736-fig6){#fig6}

We next tested whether hypertrophic chondrocytes that re-enter the cell cycle also express known skeletal stem cell markers. In mice, *LepR* expression marks a heterogeneous population of cells in endochondral bone, including a putative postnatal skeletal stem cell population ([@bib44]). First, we examined expression of *lepr* and found dynamic expression in the zebrafish Ch endochondral bone from juvenile through adult stages. A comparison with the hypertrophic chondrocyte and early osteoblast marker *runx2b* shows higher *lepr* expression in proliferative versus hypertrophic chondrocytes at 8, 12, and 20 mm SL stages, with chondrocyte expression decreasing by 27 mm SL ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}). During remodeling of zebrafish Ch (15 mm SL), we also observe *lepr*+ cells in the marrow cavity that are derived from chondrocytes, based on labeling by *col2a1a/B \> R* ([Figure 6C](#fig6){ref-type="fig"}), and we continue to observe *lepr*+ cells in the Ch marrow at later stages (20 and 27 mm SL) ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}). These results are consistent with *lepr*+ cells in the bone marrow deriving from growth plate chondrocytes in zebrafish, although direct evidence will be needed to determine if any of these chondrocyte-derived *lepr+* marrow cells behave as skeletal stem cells in zebrafish.

Requirement of *mmp9* for growth plate remodeling and marrow adipocyte formation {#s2-7}
--------------------------------------------------------------------------------

In mice, *Mmp9* has been reported to function in hematopoietic lineage cells for growth plate remodeling, as bone marrow transplants can rescue the delay in growth plate remodeling seen in *Mmp9* mutants ([@bib39]). Here, we tested whether *mmp9* might have a conserved requirement for growth plate remodeling in zebrafish, including the generation of marrow adipocytes. At the beginning of remodeling (11 mm SL), we observe expression of *mmp9* at the edge of the hypertrophic zone, with this restricted expression in late-stage hypertrophic chondrocytes continuing through 17 mm SL stages ([Figure 7A](#fig7){ref-type="fig"}). Higher magnification views show that *mmp9* expression is prominent in hypertrophic chondrocytes that appear to be exiting their lacunae. Next, we used CRISPR/Cas9 mutagenesis to create an early frame-shift mutation in the *mmp9* gene that is predicted to abolish most if not all protein function ([Figure 7B](#fig7){ref-type="fig"}). *mmp9* homozygous mutants are adult viable and do not display obvious larval craniofacial defects. Whereas trichrome staining revealed no significant differences in the mutant Ch growth plates at 17 mm SL, by 21 mm we observed that the hypertrophic zone was significantly larger, compared to the proliferative zone, in *mmp9* mutants versus controls, indicating a delay in growth plate remodeling ([Figure 7C,D](#fig7){ref-type="fig"}). The defect in growth plate remodeling was still evident at 27 mm SL, with mutants displaying a wider Ch growth plate ([Figure 7E,G](#fig7){ref-type="fig"}). Strikingly, *mmp9* mutants also had fewer adipocytes in the central marrow cavity compared to stage-matched controls ([Figure 7E,G](#fig7){ref-type="fig"}), consistent with adipocytes deriving from hypertrophic chondrocytes that are released from the cartilage matrix by Mmp9 activity.

![Tissue-autonomous requirement for *mmp9* in cartilage remodeling.\
(**A**) Colorimetric mRNA in situ hybridization shows expression of *mmp9* (blue) in sections of the Ch at 11 and 17 mm SL. Inset shows specific expression of *mmp9* in hypertrophic chondrocytes (arrows) at the edge of the growth plate. Nuclear fast red was used as a counterstain. *n* = 2 at each stage. (**B**) Schematic of the *mmp9* gene locus in zebrafish. Rectangles denote exons. The site of the 8 bp deletion in the *el734* allele is indicated by an arrow, with specific sequence changes shown below. This frame-shift mutation is predicted to result in an early stop codon and loss of the catalytic metalloproteinase domain. (**C**) Trichrome staining at 21 mm SL shows enlarged growth plates in the Ch bones of *mmp9* mutants. The approximate regions of the proliferative zones used for quantification in (**D**) are shown by the yellow ovals. (**D**) Quantification of the ratio of the hypertrophic to the proliferative zones shows a delay in remodeling the hypertrophic zone in *mmp9* mutants at 21 but not 17 mm SL. We performed a students t-test and show standard error of the mean. (**E,F**) Dissected Ch bones at adult stages (27--31 mm SL) from wild-type, *mmp9* mutant, and wild-type and mutant hosts receiving wild-type donor neural crest transplants (blue). Ectoderm cells from *bactin2*:tagBFP \>DsRed donors were transplanted unilaterally into the neural crest precursor domain of unlabeled hosts at six hpf. Red two-sided arrows indicate the width of the posterior growth plates. (+) denotes sides receiving transplants, and (-) denotes contralateral control sides. The rescued growth plate from the *mmp9* mutant receiving a wild-type neural crest transplant is shown at higher magnification in (**F**), with blue arrows showing a narrower wild-type growth plate clone and magenta arrows a wider mutant clone. (**G**) Quantification shows that *mmp9* mutants have wider growth plates and fewer adipocytes in the marrow than wild-type siblings. Wild-type neural crest transplants rescue growth plate width in *mmp9* mutants, with a trend toward better rescue in areas of the growth plate with wild-type (blue) versus mutant (magenta) clones. There was also a strong trend toward rescue of adipocyte number with wild-type neural crest transplants that contributed to growth plate chondrocytes. We performed a Tukey-Kramer HSD test and show standard error of the mean. Unless indicated, all other comparisons were not significant (p \> 0.05). Scale bars = 50 μm (**A,C**), 200 μm (**E, F**). See also [Figure 7---source data 1](#fig7sdata1){ref-type="supplementary-material"}.\
10.7554/eLife.42736.015Figure 7---source data 1.Quantification of growth plate width and adipocyte numbers in *mmp9* mutants and rescued experiments.](elife-42736-fig7){#fig7}

Given *mmp9* expression in late-stage hypertrophic chondrocytes, we next tested whether Mmp9 might function in chondrocytes as opposed to hematopoietic lineage cells for growth plate remodeling and marrow adipocyte generation in zebrafish. As the Ch bone is generated from neural crest-derived cells, we used transplantation of ubiquitously labeled wild-type ectodermal cells into the neural crest precursor domain of unlabeled *mmp9*-/- shield-stage hosts to generate wild-type Ch bones in otherwise mutant hosts. At adult stages, we were able to recover eight mutant recipients with contribution of wild-type cells to chondrocytes of the Ch growth plate. In these animals, we observed a rescue of growth plate width, with a trend toward better rescue in wild-type versus mutant regions of the growth plate (p = 0.06), as well as a trend toward rescue of adipocyte number (p = 0.06) ([Figure 7E--G](#fig7){ref-type="fig"}). As a control, transplantation of wild-type neural crest cells into wild-type animals had no effect on Ch growth plate width and adipocyte number. These results indicate that *mmp9* is required in the neural crest lineage, and potentially chondrocytes themselves, for efficient remodeling of the growth plate and the generation of marrow adipocytes from chondrocytes.

Discussion {#s3}
==========

Despite anatomical differences between zebrafish and mammalian bones, we find that growth plate remodeling is remarkably well conserved and thus likely ancestral to bony vertebrates. The zebrafish Ch undergoes a transient breakdown of cortical bone near the growth plates, which coincides with extensive vascularization and an Mmp9-dependent replacement of hypertrophic chondrocytes with fat and bone. Using multiple methods of lineage tracing, including a Cre-independent technique, we show that late-stage hypertrophic chondrocytes generate not only osteoblasts but also marrow adipocytes in zebrafish. Further support for the ability of chondrocytes to generate adipocytes is that delayed growth plate remodeling in *mmp9* mutants results in a paucity of marrow adipocytes in adults. Lastly, we show that hypertrophic chondrocytes re-enter the cell cycle and contribute to *lepr*+ mesenchymal cells, raising the possibility that partial dedifferentiation into proliferative progenitors underlies chondrocyte fate transitions inside endochondral bones.

As zebrafish have hollow bones that lack hematopoiesis, one possibility was that most if not all of the cortical bone of adult zebrafish would be simply derived from the periosteum. However, we find significant contribution of chondrocyte-derived cells to both the endosteal and periosteal surfaces of the Ch bone, similar to what has been described in the mouse ([@bib42]; [@bib43]; [@bib17]). We also reveal chondrocytes to be a significant source of marrow adipocytes in zebrafish. Although the incomplete conversion efficiency of the CreER lines, as well as the expression of *sox10*:CreER outside of chondrocytes, made it difficult to precisely quantify what proportion of osteoblasts and marrow adipocytes derive from chondrocytes, there are likely other sources for these cells, in particular the periosteum which houses several types of skeletal stem cells ([@bib6]). Our findings raise the question of whether marrow adipocytes also derive in part from chondrocytes in mammals. Indeed, older studies have demonstrated the ability of murine chondrocytes to differentiate into adipocytes in vitro ([@bib11]; [@bib12]). Further, *Col2a1*:CreER cells converted at postnatal day three in mouse were found to give rise to adipocytes in the metaphyseal bone marrow, although a caveat is that *Col2a1*:CreER marks both chondrocytes and progenitors at early postnatal stages ([@bib30]).

The finding that late-stage hypertrophic chondrocytes can re-enter the cell cycle and express *lepr* suggests that at least some of these cells may dedifferentiate into stem-like cells, which subsequently expand in number and differentiate into osteoblasts and adipocytes. Future molecular profiling of these chondrocyte-derived marrow mesenchymal cells will be needed to better characterize their relationship to previously identified skeletal stem cells. We also cannot rule out that some hypertrophic chondrocytes directly change into adipocytes and/or osteoblasts in the absence of cell division (i.e. 'transdifferentiation'). Indeed, the detection of osteoblasts with strong *col2a1a*:Histone2A-mCherry signal suggests that in some cases chondrocytes can form osteoblasts with little to no cell division, as otherwise the Histone2A-mCherry signal would have been diluted out with successive cell divisions. On the other hand, osteoblasts farther from the growth plate tended to have weaker Histone2A-mCherry signal, suggesting proliferation of a progenitor intermediate, and we directly observed late-stage hypertrophic chondrocytes undergoing cell division. Whereas it has been suggested in mouse that only chondrocytes near the periosteal surface, that is 'borderline chondrocytes', may be capable of lineage plasticity ([@bib2]; [@bib24]), we detected lineage clones containing growth plate chondrocytes, mesenchymal cells, and adipocytes in the central part of the growth plate ([Figure 3E,F](#fig3){ref-type="fig"}), arguing against such a model.

A notable feature of *LepR*-lineage cells in mice is that they contribute to osteoblasts and adipocytes primarily in postnatal phases, that is when growth plate remodeling is already underway ([@bib42]). It would therefore be interesting to test whether *LepR*-expressing skeletal stem cells have a similar origin from hypertrophic chondrocytes in mammals. One caveat is that we detect endogenous *lepr* expression in both marrow cells and growth plate chondrocytes in zebrafish. However, the more specific labeling of marrow cells by the *LepR*-Cre in mouse likely reflects the Cre insertion being in the long *LepR* isoform (containing exon 18b) that displays more restricted expression than the short isoform ([@bib44]). Indeed, *LepR* mRNA and protein has also been reported in chondrocytes of mouse ([@bib13]), rat, and human ([@bib27]), a finding we confirmed in the postnatal mouse femur, including the same higher expression in immature versus hypertrophic chondrocytes that we observe in zebrafish ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}). Without a comparable long-isoform *lepr*-Cre line in zebrafish, we cannot therefore conclude whether zebrafish *lepr*+ marrow cells are comparable to those described in mouse. The future generation of Cre lines to specifically mark *lepr*+ marrow cells in zebrafish will be needed to determine whether these chondrocyte-derived marrow cells also act as stem cells for osteoblasts and adipocytes in post-embryonic fish.

A similar delay in the remodeling of the hypertrophic zone in mouse *Mmp9* and zebrafish *mmp9* mutants reveals genetic conservation of growth plate remodeling from fish to mammals. In contrast to mice, we find that Mmp9 in zebrafish appears to function primarily in chondrocytes for growth plate remodeling. We also observed rescue of marrow adipocyte number by wild-type chondrocytes, though this had moderate statistical significance (p = 0.06), potentially owing to low sample size (*n* = 8), the mosaic contribution of wild-type cells to the growth plate, and/or roles of cells outside the growth plate to marrow adipocyte generation. In mice, loss of *Mmp13* in chondrocytes does result in a growth plate remodeling delay, with global *Mmp13* deletion enhancing the remodeling defects of *Mmp9* mutants ([@bib15]; [@bib37]). It may be that MMPs are derived from both chondrocytes and invading hematopoietic cells (e.g. osteoclasts), with the relative importance of each cell source varying between zebrafish and mammals. Compensation by *mmp13* might also explain why we detected growth remodeling defects in *mmp9* zebrafish mutants at 21 and 27--31 mm SL stages, but not at 17 mm SL. Mmp9 and Mmp13 have known roles in degrading components of the cartilage extracellular matrix ([@bib31]), consistent with our observed loss of collagen-rich matrix in hypertrophic chondrocytes at the edges of the zebrafish growth plate. Secreted Mmp9 may therefore function simply to degrade cartilage matrix and facilitate release of dedifferentiating chondrocytes into the marrow. Intriguingly, Mmp9 has recently been shown to have an additional, non-canonical function in the nucleus for histone H3 tail cleavage. Whereas this has only been demonstrated so far for osteoclasts ([@bib19]), it remains possible that Mmp9 could have a similar non-canonical function in altering the chromatin structure of hypertrophic chondrocytes to allow them to acquire new potential. In conclusion, our data support conservation of mammalian-like growth plate remodeling in zebrafish, which provides new opportunities for better understanding the molecular and cellular mechanisms by which hypertrophic chondrocytes transform into osteoblasts, marrow adipocytes, and potentially adult skeletal stem cells within endochondral bones.

Materials and methods {#s4}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent\                       Designation                                             Source or\                  Identifiers                                                                           Additional\
  type (species)\                                                                        reference                                                                                                         information
  or resource                                                                                                                                                                                              
  ------------------------------ ------------------------------------------------------- --------------------------- ------------------------------------------------------------------------------------- ---------------------------------------------------------
  Genetic reagent (*D. rerio*)   *sp7:EGFP*                                              PMID: 20506187              RRID: ZFIN ID: ZDB-GENO-100402--2                                                     Zebrafish International Resource Center

  Genetic reagent (*D. rerio*)   *Hsa.RUNX2:EGFP*                                        PMID: 23155370              RRID: ZFIN ID: ZDB-ALT-120209--60                                                     Zebrafish International Resource Center

  Genetic reagent (*D. rerio*)   *Mmu.Sox10-Mmu.Fos:Cre*                                 PMID: 23155370              RRID: ZFIN ID: ZDB-ALT-130614--2                                                      Zebrafish International Resource Center

  Genetic reagent (*D. rerio*)   *Ola.Osteocalcin.1:EGFP*                                PMID: 21571227              RRID: ZFIN ID: ZDB-ALT-110713--1                                                      Zebrafish International Resource Center

  Genetic reagent (*D. rerio*)   *col2a1aBAC:GFP*                                        PMID: 26555055              RRID: ZFIN ID: ZDB-ALT-160204--6                                                      Zebrafish International Resource Center

  Genetic reagent (*D. rerio*)   *col2a1aBAC: mCherry-NTR*                               PMID: 26555055              RRID: ZFIN ID: ZDB-ALT-160204--7                                                      Zebrafish International Resource Center

  Genetic reagent (*D. rerio*)   *bactin2:loxP-BFP-loxP-DsRed*                           PMID: 25119047              RRID: ZFIN ID: ZDB-ALT-141111--8                                                      Zebrafish International Resource Center

  Genetic reagent (*D. rerio*)   *fli1a:eGFP*                                            PMID: 12167406              RRID: ZFIN ID: ZDB-ALT-\                                                              Zebrafish International Resource Center
                                                                                                                     060810--2                                                                             

  Genetic reagent (*D. rerio*)   *kdrl:eGFP*                                             PMID: 16251212              RRID: ZFIN ID: ZDB-ALT-061120--6                                                      Zebrafish International Resource Center

  Genetic reagent\               (−5.2)lyve1b:DsRed                                      PMID: 22627281              RRID: ZFIN ID: ZDB-ALT-120723--3                                                      Zebrafish International Resource Center
  (*D. rerio*)                                                                                                                                                                                             

  Genetic\                       *ubb:LOX2272-LOXP-RFP-LOX2272-CFP-LOXP-YFP*             PMID: 23757414              RRID: ZFIN ID: ZDB-ALT-130816--2                                                      Zebrafish International Resource Center
  reagent\                                                                                                                                                                                                 
  (*D. rerio*)                                                                                                                                                                                             

  Genetic\                       *sox10:CreERT2: bactin2:loxP-BFP-loxP-DsRed*            this paper                                                                                                        allele *el777*
  reagent\                                                                                                                                                                                                 
  (*D. rerio*)                                                                                                                                                                                             

  Genetic\                       *col2a1a-R2-E1b:CreERT2::bactin2:loxP-BFP-loxP-DsRed*   this paper                                                                                                        allele *el691*
  reagent\                                                                                                                                                                                                 
  (*D. rerio*)                                                                                                                                                                                             

  Genetic\                       *col2a1a-R2-E1b:CreERT2::bactin2:loxP-BFP-loxP-DsRed*   this paper                                                                                                        allele *el713*
  reagent\                                                                                                                                                                                                 
  (*D. rerio*)                                                                                                                                                                                             

  Genetic\                       *col2a1a-R2-E1b:CreERT2::bactin2:loxP-BFP-loxP-DsRed*   this paper                                                                                                        allele *el712*
  reagent\                                                                                                                                                                                                 
  (*D. rerio*)                                                                                                                                                                                             

  Genetic reagent (*D. rerio*)   *col2a1a-R2-E1b:H2A.F/Z-mCherry-P2A-GFPCAAX*            this paper                                                                                                        allele *el690*

  Genetic reagent (*D. rerio*)   *col2a1a-R2-E1b:H2A.F/Z-mCherry-P2A-GFPCAAX*            this paper                                                                                                        allele *el695*

  Genetic reagent (*D. rerio*)   *mmp9^-/-^*                                             this paper                                                                                                        allele *el734*; gRNA target 5'-TTGATGCCATGA AGCAGCCC-3'

  Recombinant DNA reagent        p5E-sox10                                               PMID: 22589745              RRID: ZFIN ID: ZDB-ALT-120523--6                                                      Zebrafish International Resource Center

  Recombinant DNA reagent        pDestTol2-col2a1aR2-E1B-eGFPpA                          PMID: 21723274              RRID: ZFIN ID: ZDB-ALT-111205--4                                                      Zebrafish International Resource Center

  Antibody                       rat anti-BrdU                                           Bio-Rad Laboratories        cat.\#: MCA2060 GA; RRID: [AB_10545551](https://scicrunch.org/resolver/AB_10545551)   (1:100--150)

  Antibody                       rabbit anti-mCherry                                     Novus Biologicals           cat.\#:NBP2-25157                                                                     (1:250)

  Antibody                       goat anti-rabbit Alexa Fluor 568                        Thermo Fisher Scientific    cat.\#: A-11011; RRID:[AB_143157](https://scicrunch.org/resolver/AB_143157)           (1:200--500)

  Antibody                       goat anti-rat Alexa Fluor 633                           Thermo Fisher Scientific    cat.\#: A21094; RRID: [AB_2535749](https://scicrunch.org/resolver/AB_2535749)         (1:500)

  Sequence-based reagent         RNAscope Probe - Mm-Lepr                                Advanced Cell Diagnostics   cat.\#: 402731                                                                        

  Sequence-based reagent         RNAscope Probe - Dr-lepr                                Advanced Cell Diagnostics   cat.\#: 535311                                                                        

  Sequence-based reagent         RNAscope Probe - Dr-runx2b-C2                           Advanced Cell Diagnostics   cat.\#: 409531-C2                                                                     

  Commercial assay or kit        Gomori One-Step, Aniline Blue, trichrome stain kit      Newcomer Supply             cat.\#: 9176A                                                                         

  Commercial assay or kit        Movat-Russell modified penta-chrome stain kit           Newcomer Supply             cat. \#: 9150A                                                                        

  Commercial assay or kit        RNAscope Multiplex Fluorescent Kit v2                   Advanced Cell Diagnostics   cat.\#: 323110                                                                        

  Chemical compound, drug        Alizarin Red S                                          Amresco                     cat.\#: 9436--25G                                                                     live staining: 1 mg / 30 mL

  Chemical compound, drug        Calcein Green                                           Thermo Fisher Scientific    cat.\#: C481                                                                          live staining:1 mg / 10 mL

  Chemical compound, drug        Calcein Blue, AM                                        Thermo Fisher Scientific    cat.\#: C1429                                                                         live staining: 5 mg / 10 mL

  Chemical compound, drug        (Z)−4-Hydroxy-tamoxifen (4-OHT)                         Sigma-Aldrich               cat.\#: H7904                                                                         Cre-lox Recombination: 5 uM

  Chemical compound, drug        HCS LipidTOX Deep Red                                   Life Technologies           cat.\#: H34477                                                                        (1:200)

  Chemical compound, drug        BrdU −5-Bromo-2′-deoxyuridine                           Sigma-Aldrich               cat.\#: B5002                                                                         live staining: 4.5 mg / mL

  Software                       Prism                                                   GraphPad                                                                                                          

  Software                       FIJI                                                    Image J                                                                                                           
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Zebraﬁsh transgenic lines and *mmp9* mutants {#s4-1}
--------------------------------------------

All procedures were approved by the University of Southern California Institutional Animal Care and Use Committee. Published *Danio rerio* lines include *Tg(Has.RUNX2:EGFP)^zf259^* and *Tg(Mmu.Sox10-Mmu.Fos:Cre)^zf384^* ([@bib18]), *Tg(sp7:EGFP)^b1212^* ([@bib7]), *Tg(Ola.Osteocalcin.1:EGFP)^hu4008^* ([@bib20]), *Tg(col2a1aBAC:GFP)^el483^* and *Tg(col2a1aBAC:mCherry-NTR)^el559^* ([@bib1]), *Tg(bactin2:loxP-BFP-loxP-DsRed)^sd27^* ([@bib21]), *Tg(fli1a:eGFP)^y1^* ([@bib23]), Tg(*kdrl:eGFP)^s843^* ([@bib16]), *Tg(−5.2lyve1b:DsRed)^nz101^* ([@bib29]), and Zebrabow - *Tg(ubb:LOX2272-LOXP-RFP-LOX2272-CFP-LOXP-YFP)^a131^* ([@bib32]). The *sox10*:CreERT2 transgene was generated with Gateway Cloning (Invitrogen) and the Tol2 kit ([@bib22]) by combining p5E-sox10 ([@bib5]), pME-CreERT2, p3E-pA, and pDestTol2pA2. The *col2a1a-R2-E1b*:CreERT2 and *col2a1a-R2-E1b*:H2A.F/Z-mCherry-P2A-GFPCAAX transgenes utilize a zebrafish *col2a1a* R2 enhancer element with a minimal E1B promoter sequence ([@bib4]). For *col2a1a-R2-E1b*:CreERT2, CreERT2 was amplified using pENTR/D-CreERT2 as template and primers 5'- TTCTTGTACAAAGTGGCCACCGGCCACCATGTCCAATTTACTGACCGTACAC-3' and 5'-TAGAGGCTCGAGAGGCCTTGTCAAGCTGTGGCAGGGAAACCCTC-3'. The amplified PCR product was combined with an NcoI/EcoRI fragment of pDestTol2-col2a1aR2-E1B-eGFPpA ([@bib1]) using Gibson Assembly (New England Biolabs). For *col2a1a-R2-E1b*:H2A.F/Z-mCherry-P2A-GFPCAAX, H2A.F/Z-mCherry was amplified using template pME-H2A.F/Z-mCherry and primers 5'-TTTCTTGTACAAAGTGGCCAAAGCTTGGATCCCGGCCACCATGGCAGGTGGAAAAGCAGG-3' and 5'-AAGTTGGTTGCTCCCGACCCCTTGTACAGCTCGTCCATGCCGCCGGTG-3'. P2A-GFPCAAX was synthesized as a gBlock (IDT). H2A.F/Z-mCherry and P2A-GFPCAAX were combined with an NcoI/EcoRI fragment of pDestTol2-col2a1aR2-E1B-eGFPpA using Gibson Assembly. All transgenes were injected at 30 ng/μL along with 50 ng/μL Tol2 mRNA into one-cell-stage embryos, with these animals raised and outcrossed to identify stable germline founders. CreERT2 transgenes were injected into *Tg(bactin2:loxP-BFP-loxP-DsRed)^sd27^* embryos, followed by overnight treatment with 10 μM (Z)−4-Hydroxytamoxifen (4-OHT) (Sigma-Aldrich H7904) at two dpf and screening for DsRed+ chondrocytes at six dpf using a Leica fluorescent stereomicroscope. Embryos with fluorescent cartilages were raised to adulthood and outcrossed to identify founders. We used *Tg(sox10:CreERT2)^el777^*, *Tg(col2a1a-R2-E1b:CreERT2)^el712^*, and *Tg(col2a1a-R2-E1b:H2A.F/Z-mCherry-P2A-GFPCAAX)^el695^* lines for our experiments. Two additional alleles of *Tg(col2a1a-R2-E1b:CreERT2)* and one additional allele of *Tg(col2a1a-R2-E1b:H2A.F/Z-mCherry-P2A-GFPCAAX)* gave similar cartilage-specific expression. To generate *mmp9^el734^* we used CRISPR/Cas9 mutagenesis to target the second exon. gRNA targeting the sequence 5'-TTGATGCCATGAAGCAGCCC-3' was injected at 25 ng/μl with 50 ng/μl Cas9 RNA into one-cell-stage embryos as described ([@bib14]). The *mmp9^el734^* allele is an 8 bp deletion that results in the incorporation of 13 additional amino acids after amino acid 98 (P), followed by a premature stop codon that is predicted to completely abolish the catalytic metalloproteinase domain.

Histology and LipidTOX staining {#s4-2}
-------------------------------

Live bone staining of dissected ceratohyal bones was performed by treating with 50 µg/ml Alizarin Red (Sigma Aldrich, cat. no. A5533), Calcein Green (Thermofisher Scientific, cat. no. C481), or Calcein Blue, AM (Thermofisher Scientific, cat. no. C1429) for 5 min and repeatedly rinsing in embryo medium as described ([@bib34]). We performed adipocyte labeling of dissected ceratohyal bones by incubating in a 1:200 solution of HCS LipidTOX Deep Red (Life Technologies, cat. no. H34477) for 15 min and rinsing in embryo medium as described ([@bib26]). Paraffin embedding and histology were performed as described ([@bib34]). We cut blocks into 5 μm sections on a Shandon Finesse Me+ microtome (cat. no. 77500102) and collected sections on Apex Superior Adhesive slides (Leica Microsystems, cat. no. 3800080). Pentachrome and Trichrome staining were performed according to manufacturer\'s instructions (Movat-Russell modified pentachrome stain kit, Newcomer Supply cat. no. 9150A; Gomori One-Step, Aniline Blue, trichrome stain kit, Newcomer Supply cat. no. 9176A).

Immunohistochemistry and in situ hybridization {#s4-3}
----------------------------------------------

For cell proliferations assays, fish were immersed in system water containing 4.5 mg/ml BrdU (Sigma Aldrich, cat. no. B5002) for 1 hr, followed by two washes in system water, fixation in 4% paraformaldehyde, and paraffin embedding. Immunohistochemistry was performed as described except that we blocked with 2% normal goat serum (Jackson ImmunoResearch, cat. no. 005-000-121). After cutting thin sections, we performed antigen retrieval by treating slides with citrate buffer (pH 6.0) in a steamer set (IHC World, cat. no. IW-1102) for 35 min. Primary antibodies include rat anti-BrdU (1:100, Bio-Rad, cat. no. MCA2060GA) and rabbit anti-mCherry (1:250, Novus Biologicals, cat. no. NBP2-25157). We used AlexaFluor secondary antibodies and Hoechst to visualize nuclei. Colorimetric in situ hybridization was performed as described ([@bib34]). The *mmp9* riboprobe was generated by PCR amplification of zebrafish genomic DNA with primers 5'-GTCTCCAATACTAAAGCTCTGAAGAAG-3' and 5-'TAGGATGTCGAAGGTCTATAGAGAATG-3' and cloning into pCR-BluntII-TOPO (Life Technologies). RNA probe was synthesized with T7 polymerase (Roche) after linearizing the plasmid with BamHI restriction. RNAscope probes for *leptin receptor* (*lepr*) and *runx2b* were synthesized by Advanced Cell Diagnostics in Channel 1 and Channel 2, respectively, and for mouse *Lepr* in channel 1. Paraformaldehyde-fixed paraffin-embedded sections were deparaffinized, and the RNAscope fluorescent multiplex v2 assay combined with immunofluorescence was performed according to manufacturer's protocols and with the ACD HybEZ Hybridization oven.

Neural crest transplantations {#s4-4}
-----------------------------

At six hpf, donor ectoderm from the animal cap of *bactin2*:loxP-tagBFP-loxP-DsRed embryos was transplanted into the neural crest precursor domain of *mmp9^-/-^* hosts as described ([@bib3]). Embryos displaying unilateral tagBFP fluorescence in the face at three dpf were raised in the nursery and then genotyped at 14 dpf for the *mmp9* mutant allele. Homozygous mutant and wild-type siblings were raised at similar density until they reached the indicated sizes for analysis.

Imaging {#s4-5}
-------

Brightfield images of pentachrome and trichrome stains, and colorimetric in situ hybridizations, were acquired with a Zeiss AxioImager.A1 microscope and a Zeiss slide scanner AxioScan.Z1. Focus stacking of multiple images was done in Adobe Photoshop CS5. Fluorescence images were captured on a Zeiss LSM800 confocal microscope, with representative sections or maximum intensity projections shown as specified. Tiling was performed using ZEN software or manually stitched together using Fiji. Brightness and contrast were adjusted in Adobe Photoshop CS5 with similar settings for experimental and control samples.

Quantification and statistical analyses {#s4-6}
---------------------------------------

We stage-matched control and experimental zebrafish by measuring standard body length (SL) from the tip of the snout to the edge of the hypuralia. Adipocyte counts and area/width measurements of growth plates were calculated using Fiji. The proliferative zone of the growth plate was defined as the central region of compact chondrocytes. All measurements were performed blinded to genotype. Statistical significance was determined by a student's t-test for pair-wise comparisons or Tukey-Kramer HSD tests for multiple comparisons, using GraphPad's Prism software.
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Reviewing Editor: All agree the work is novel and represents potentially important differences with the more frequently studied mammalian systems. As such there is support for the manuscript. But there are several limitations that need to be addressed in a revision. First a clearer characterization of *LepR*+ cells is required since the authors conclusions differ from the kinetics in mice, raising an important distinction if true between fish and mammals. The comparisons between species however, are further limited by the difference in the *LepR* isoform used in the Cre lines between those of Morrison and in this work. Second, several components of Figure 3 are not clear and raise questions about labeling and timing of 4OHT- this aspect will require more experiments. Third, the results from the *MMP9* mutation are not directly related to the major tenet of the manuscript and the rescue experiments are based on small numbers of fish. Finally, it is conceptually difficult to appreciate the authors conclusions that the marrow adipocytes represent a fat reserve and that hematopoiesis follows later- there are no data to support that assumption. Are the authors suggesting the adipocyte depot represents a place holder for subsequent hematopoiesis?

As such these four points plus other comments from the reviewers will require more experiments and a comprehensive revision.

*Reviewer \#1:*

This elegant and well written manuscript describes how chondrocytes in the zebrafish CH cartilage template gives rise to osteoblasts and adipocytes during CH bone maturation. The studies show that the CH cartilage template undergoes remodeling and vascularization during juvenile stages to generate fat-filled bones in the adult. Growth plate chondrocytes re-enter the cell cycle, and express the progenitor cell marker leptin receptor, suggesting dedifferentiation into progenitor cells, and then re-differentiation into osteoblasts, adipocytes and mesenchymal cells within the adult CH.

This study answers the important question as to whether zebrafish bone arises through invasion of the vasculature and conversion of growth plate cartilage to bone, as occurs in mammals. And also whether hypertrophic chondrocytes directly transform into osteoblast, or do so through a stem cell intermediate. This study identifies growth plate chondrocytes as a source of osteocytes and adipocytes in zebrafish bones, and suggest that dedifferentiation into proliferative progenitors as the likely mechanism.

The authors describe the bidirectional growth of the zebrafish CH growth plates (in contrast to mammalian unidirectional growth plates in long bones), and use beautiful lineage labeling studies to show chondrocyte clonal cell contributions to mesenchymal cells and adipocytes -- and possibly osteoblasts -- after growth plate remodeling.

Multiple approaches are used to demonstrate that hypertrophic chondrocytes and their osteoblast derivatives undergo cell division, indicating a dedifferentiation of hypertrophic chondrocytes. Conversion of hypertrophic chondrocytes to osteoblasts/adipocytes via transdifferentiation or through partial de-differentiation into a proliferative progenitor was examined using BrdU labeling. The expression of the progenitor cell marker *lepr* was used to monitor hypertrophic chondrocyte differentiation and de-differentiation into a progenitor cell-like state.

The authors conclude that growth plate remodeling is a conserved feature of bony vertebrates, and that chondrocyte dedifferentiation is a mechanism to generating osteoblasts and marrow adipocytes in the zebrafish. They also describe roles for *Mmp9*/13 in this process.

I recommend that this manuscript be accepted for publication in *eLife*.

Strengths:

1\) Beautiful imaging, well described and careful studies.

2\) The finding that late-stage hypertrophic chondrocytes give rise to osteoblasts and marrow adipocytes in the zebrafish CH.

3\) Chondrocytes also give rise to both endosteal and periosteal surfaces fo the Ch bone, similar to mouse.

4\) Demonstration that *mmp9* is required, in the neural crest cell lineage and perhaps in chondrocytes themselves, for Ch growth plate width, remodeling and adipocyte number, using both *mmp9* mutant and rescue by WT cell transplantation into *mmp9* mutant zebrafish.

5\) The finding that growth plate remodeling is well conserved between mammals and fishes.

6\) Use of three different methods of lineage tracing, including a Cre independent technique, to show that late-stage hypertrophic chondrocytes generate not only osteoblasts but also marrow adipocytes in zebrafish.

7\) The interesting hypothesis that evolutionarily, fish bone marrow may represent the ancestral condition of being primarily a fat reservoir, with hematopoiesis moving into the bone later during tetrapod evolution.

8\) The intriguing hypothesis that *mmp9* may have additional non-canonical function in the nucleus for histone H3 tail cleavage in hypertrophic chondrocytes, as has been demonstrated for osteoclasts.

9\) Discrepancies with the mouse *lepr* expression patterns is discussed, and proposed that this may be due to the more restricted expression of the long *LepR* isoform (mouse) as compared to the short isoform. Direct analyses of the two isoforms in zebrafish is proposed.

*Reviewer \#2:*

This manuscript elegantly demonstrates the significant contribution of hypertrophic chondrocytes to bone marrow fat in zebrafish. The authors also provide solid data to back their conclusions and suggest a novel mechanism of de-differentiation.

However, I have two comments about the context and the data presented in this article:

1\) Although they mentioned the possibility that chondrocytes differentiate into adipocytes in mammals in the discussion, the authors missed on placing their findings with the current literature in mammals, notably mouse studies. Murine chondrocytes cultures can differentiate in adipocytes in vitro. Also, Ono et al., 2014, have previously showed that Col2CRE-ER dtomato mice do not show adipocyte labelling at 1 week, 1month or even 1 year after tamoxifen induction. It would be interesting for the authors to mention whether this specific to fish or not.

2\) Would it be possible for the authors to quantify the contribution of chondrocytes to the total number of adipocytes? In other words, what is the ratio of labelled vs non-labelled adipocytes in their adult animals?

3\) Is it possible that WT donor cells coming from WT did not rescue the number of adipocytes in *mmp9* mutants because of the low n in that experiment (i.e. n = 2)? If so, the authors should mention the limitation of a low n.

*Reviewer \#3:*

In this manuscript, Giovannone et al. examine the results of neural crest and cartilage lineage tracing in a zebrafish model, that chondrocytes can contribute to mesenchyme in the endosteal compartment. Overall, the observations made here mostly mirror previously published studies in mouse systems. While there are novel insights to be gained from further lineage tracing studies in a zebrafish system to understand if these findings are conserved, the existence of extensive prior literature utilizing this approach in mice generally limits the additional novel insights to be gained unless the findings of this system are pursued in substantial depth, which is largely not the case in the present manuscript.

A few potentially significant novel observations are made but not followed up upon. For example, the labeling with the *Col2a1* system performed here is very restricted compared with use of similar reagents in mice. This is of interest for suggesting that the presence of chondrocyte-like gene expression signatures in bona fide MSCs is restricted to mammalian systems and therefore a recent evolutionary development. However, this is not explored in sufficient detail to flesh out this possibility and draw clear conclusions on this point. Similarly potentially interesting observations are made regarding the origin of *LEPR*+ cells, however these are not explored in sufficient detail to provide clear answers as to the origin of marrow resident *LEPR* cells. Additional specific comments are described below:

Major points:

1\) It is unclear if the timing of 4-OHT administration truly restricts Sox10-cre ERT driven recombination to cartilage and not to other populations of neural crest-derived progenitors of the Ch bone. Indeed, the labeling of the periosteum observed suggests that the latter possibility is more likely. Given that Sox10 may label neural crest-derived mesenchymal progenitors beyond just chondrocytes, the use of Sox10-based lineage tracking is problematic for experiments designed to inform on chondrocyte conversion into osteoblast or adipocyte-lineage cells. The comparison to the broader deletion mediated by the human Sox10-cre is helpful, but does not exclude labeling of other non-cartilage MSC populations. It is appreciated that the *Col2a1* system addresses some of these weaknesses of the Sox10 system.

2\) The images shown in Figure 3E are not convincing that they represent solely labeling of 3 independent clones as the regions of the distinct clones appear to partially overlap in the image available, undercutting the claim of clonal labeling. Titration studies of 4-OHT are needed to establish the dose ranges where clonal labeling is observed. Moreover even with full validation of a dose titration series, it is impossible to be certain that labeling represents true single clone derivatives unless either serial imaging is performed or a multiclone reporter similar to the confetti mouse is used. The suggestion that *col2a1*-mediated labeling is restricted in zebrafish relative to observations made in mice is interesting for suggesting that the presence of a chondrocyte-like gene expression program in MSC populations is restricted to mammals. However, further experiments to directly assess this would be needed to flesh out this possibility.

3\) A major limitation of this study is that it only tracks cells but does not assess their functional contribution to mineralizaiton, for instance by deleting a gene required for mineralization using *Col2a1*-cre in zebrafish and observing the actual phenotypic contribution of post-chondrocyte osteoblasts to skeletal mineralization.

4\) The investigation of cartilage cells as a source of *LEPR*+ cells is primarily of interest for the suggestion that cartilage is the source of the *LEPR*+ cell populations described in mice. However, these part of the manuscript has limitations that prevent it from providing substantial insights into the question of the source of the *LEPR*+ cells as they are described in the murine system.

Aside from these concerns, one of the notable features of murine *LEPR*-cre marked cells is that *LEPR* generally excludes cells in the growth plate. Thus, the significance of *LEPR* labeling in cartilage in fish for mammalian physiology is unclear. Indeed, the labeling in cartilage appears quite weak relative to the labeling in cells adjacent to bone and it is unclear what degree of signal in this in situ hybridization based system would correspond to the cells marked by *LEPR*-cre in mice. There is also no characterization of the *LEPR*+ cells offered, so it is unclear to what degree these cells observed in zebrafish correspond functionally to murine *LEPR*+ cells. Additionally, a defining feature of murine *LEPR* osteogenic cells is that they do not emerge until adulthood. What are the kinetics of *LEPR*+ cells emerging during the lifetime of the fish?

5\) The work on *MMP9* is not strongly related to the rest of the manuscript. No direct evidence is offered to show that any of the phenotypes seen with the *MMP9* loss of function relate to transdifferentiation of cartilage cells.

6\) In Figure 6, how can it be excluded that the Brdu labeling observed is due to labeling of proliferating chondrocytes that have progressed to the hypertrophic stage by the time of visualization?

10.7554/eLife.42736.019

Author response

> Reviewing Editor: All agree the work is novel and represents potentially important differences with the more frequently studied mammalian systems. As such there is support for the manuscript. But there are several limitations that need to be addressed in a revision.
>
> First a clearer characterization of LepR+ cells is required since the authors conclusions differ from the kinetics in mice, raising an important distinction if true between fish and mammals.

In a new Figure 6---figure supplement 1, we have performed in situ analysis of *lepr* at 4 additional stages in zebrafish, as well as in situ analysis of *Lepr* in the postnatal mouse femur. These experiments show that *lepr*+ cells in the fish marrow emerge only after remodeling of the growth plate. We also find similar expression of fish *lepr* and mouse *Lepr* in chondrocytes at all stages, with expression in both species most prominent in the proliferative zone of the growth plate. We reference previous papers showing similar chondrocyte expression of *Lepr* in mouse, rat, and human, and that the marrow-specific expression of mouse *Lepr-Cre* is likely due to this transgene targeting only the long isoform of *Lepr*. In response to reviewer 3, we have modified the Discussion to stress that our results show that *lepr*+ marrow cells are derived from chondrocytes, and that further experiments are needed to determine if these are equivalent to the *Lepr-Cre*+ marrow stem cells reported in mouse.

> Second, several components of Figure 3 are not clear and raise questions about labeling and timing of 4OHT- this aspect will require more experiments.

We agree with reviewer 3 that our initial analysis using *sox10*:CreER was problematic given its expression in additional non-cartilage cells. In a new Figure 3F, we have now performed more precise clonal labeling using zebrabow fish as requested, which reveals common color clones of chondrocytes and adipocytes, and chondrocytes and putative osteocytes. This strengthens our argument that it is *sox10*:CreER-labeled chondrocytes that give rise to adipocytes and osteocytes.See response to reviewer 3 for more details.

> Third, the results from the MMP9 mutation are not directly related to the major tenet of the manuscript and the rescue experiments are based on small numbers of fish.

We disagree that the results from the *mmp9* mutant analysis are not directly related to the manuscript. The *mmp9* mutant analysis is used to make two major points. First, it was previously unclear whether fish growth plates undergo the same type of remodeling seen in mammalian bones. A common delay in growth plate remodeling in fish *mmp9* and mouse *Mmp9* mutants therefore supports genetic conservation of remodeling in both species. Second, we show that zebrafish *mmp9* functions in chondrocytes themselves for remodeling. By increasing our *n* number for rescue experiments (from *n=2* to *n=8* in the revision) we now see that restoring *mmp9* in chondrocytes rescuesadipocyte generation (revised Figure 7G). Thus, analysis of *mmp9* mutants provides important genetic evidence supporting our major tenet that remodeling of chondrocytes generates adipocytes.

> Finally, it is conceptually difficult to appreciate the authors conclusions that the marrow adipocytes represent a fat reserve and that hematopoiesis follows later- there are no data to support that assumption. Are the authors suggesting the adipocyte depot represents a place holder for subsequent hematopoiesis?

We acknowledge that this evolutionary statement was highly speculative and have therefore removed it from the Discussion.

> As such these four points plus other comments from the reviewers will require more experiments and a comprehensive revision.

Reviewer \#2:

> This manuscript elegantly demonstrates the significant contribution of hypertrophic chondrocytes to bone marrow fat in zebrafish. The authors also provide solid data to back their conclusions and suggest a novel mechanism of de-differentiation.
>
> However, I have two comments about the context and the data presented in this article:

*1) Although they mentioned the possibility that chondrocytes differentiate into adipocytes in mammals in the discussion, the authors missed on placing their findings with the current literature in mammals, notably mouse studies. Murine chondrocytes cultures can differentiate in adipocytes* in vitro*. Also, Ono et al., 2014, have previously showed that Col2CRE-ER dtomato mice do not show adipocyte labelling at 1 week, 1month or even 1 year after tamoxifen induction. It would be interesting for the authors to mention whether this specific to fish or not.*

We thank the reviewer for alerting us to these previous studies. A re-examination of (Ono et al., 2014) revealed that they did in fact observe adipocyte labeling post-chase --"During an extended chase period over a year after the pulse, Col2^creER^-P3 cells continued to yield chondrocytes, osteoblasts and stromal cells in the metaphysis, and also became adipocytes in the metaphyseal bone marrow (Figure 3C,D and Supplementary Figure 2F)". We now include a discussion of the current mouse literature.

"Indeed, older studies have demonstrated the ability of murine chondrocytes to differentiate into adipocytes in vitro (Heermeier et al., 1994; Hegert et al., 2002). Further, *Col2a1*:CreER cells converted at postnatal day 3 in mouse were found to give rise to adipocytes in the metaphyseal bone marrow, although a caveat is that *Col2a1*:CreER marks both chondrocytes and progenitors at early postnatal stages (Ono et al., 2014)."

> 2\) Would it be possible for the authors to quantify the contribution of chondrocytes to the total number of adipocytes? In other words, what is the ratio of labelled vs non-labelled adipocytes in their adult animals?

We considered quantification but concluded that it would not be skewed due to several factors. First, conversion efficiency is variable in our CreER lines. Second, perhaps due to gene silencing or the small amount of cytoplasm in mature adipocytes, we cannot always definitively detect the reporter allele (converted or unconverted) in all adipocytes. Thus, while we could certainly attempt to quantify the proportion of lineage cells, any quantification would be an under-representation of chondrocyte contribution to adipocytes.

> 3\) Is it possible that WT donor cells coming from WT did not rescue the number of adipocytes in mmp9 mutants because of the low n in that experiment (i.e. n = 2)? If so, the authors should mention the limitation of a low n.

We have now performed additional transplantation experiments and have increased our n from 2 to 8, which reveal a strong trend toward rescue of adipocyte numbers (revised Figure 7G).

"We also observed rescue of marrow adipocyte number by wild-type chondrocytes, though this had moderate statistical significance (p = 0.06), potentially owing to low sample size (*n* = 8), the mosaic contribution of wild-type cells to the growth plate, and/or roles of cells outside the growth plate to marrow adipocyte generation."

Reviewer \#3:

> In this manuscript, Giovannone et al. examine the results of neural crest and cartilage lineage tracing in a zebrafish model, that chondrocytes can contribute to mesenchyme in the endosteal compartment. Overall, the observations made here mostly mirror previously published studies in mouse systems. While there are novel insights to be gained from further lineage tracing studies in a zebrafish system to understand if these findings are conserved, the existence of extensive prior literature utilizing this approach in mice generally limits the additional novel insights to be gained unless the findings of this system are pursued in substantial depth, which is largely not the case in the present manuscript.
>
> A few potentially significant novel observations are made but not followed up upon. For example, the labeling with the Col2a1 system performed here is very restricted compared with use of similar reagents in mice. This is of interest for suggesting that the presence of chondrocyte-like gene expression signatures in bona fide MSCs is restricted to mammalian systems and therefore a recent evolutionary development. However, this is not explored in sufficient detail to flesh out this possibility and draw clear conclusions on this point. Similarly potentially interesting observations are made regarding the origin of LEPR+ cells, however these are not explored in sufficient detail to provide clear answers as to the origin of marrow resident LEPR cells. Additional specific comments are described below:

We thank the reviewer for this comment and agree that we had not previously explained key differences in the way the zebrafish *col2a1a*-CreER line was constructed compared to its equivalent in mouse. We now clarify that the col2a1a-CreER transgene was made with a cartilage-specific enhancer that we have extensively validated in a previous study (Askary et al., 2015). This avoids the weak expression of zebrafish *col2a1a* in perichondrium/periosteum, which we now reference. In the future, a zebrafish *col2a1a*-CreER knock-in line that reports full *col2a1a* expression (including in the perichondrium/periosteum) would be needed to test whether *col2a1a*+ MSCs similar to those reported by (Ono et al., 2014) also exist in zebrafish.

"In mice, *Col2a1*:CreERT2-mediated conversion at embryonic and early postnatal stages broadly labels not only chondrocytes but also osteochondroprogenitors, such as those in the perichondrium and periosteum (Ono et al., 2014). \[...\]Treatment of *col2a1a/B\>R* fish with a single dose of 4-OHT at 5 dpf resulted in extensive labeling of *col2a1a-BAC*:GFP+chondrocytes at 12 dpf, but no labeling of the perichondrium, periosteum, and osteoblasts as marked by the *sp7*:GFP transgene (Figure 4A, B; Figure 3---figure supplement 1B)."

In a new Figure 4A,B, we present additional controls (including high magnification views of the perichondrium) showing co-localization of col2a1a-CreER-converted cells with the chondrocyte marker *col2a1a-BAC*:GFP but not the osteoblast and perichondrium/periosteum marker *sp7*:GFP. These additional controls further validate the use of this CreER line to follow the long-term fates of fish chondrocytes in a specific manner.

> Major points:
>
> 1\) It is unclear if the timing of 4-OHT administration truly restricts Sox10-cre ERT driven recombination to cartilage and not to other populations of neural crest-derived progenitors of the Ch bone. Indeed, the labeling of the periosteum observed suggests that the latter possibility is more likely. Given that Sox10 may label neural crest-derived mesenchymal progenitors beyond just chondrocytes, the use of Sox10-based lineage tracking is problematic for experiments designed to inform on chondrocyte conversion into osteoblast or adipocyte-lineage cells. The comparison to the broader deletion mediated by the human Sox10-cre is helpful, but does not exclude labeling of other non-cartilage MSC populations. It is appreciated that the Col2a1 system addresses some of these weaknesses of the Sox10 system.
>
> 2\) The images shown in Figure 3E are not convincing that they represent solely labeling of 3 independent clones as the regions of the distinct clones appear to partially overlap in the image available, undercutting the claim of clonal labeling. Titration studies of 4-OHT are needed to establish the dose ranges where clonal labeling is observed. Moreover even with full validation of a dose titration series, it is impossible to be certain that labeling represents true single clone derivatives unless either serial imaging is performed or a multiclone reporter similar to the confetti mouse is used. The suggestion that col2a1-mediated labeling is restricted in zebrafish relative to observations made in mice is interesting for suggesting that the presence of a chondrocyte-like gene expression program in MSC populations is restricted to mammals. However, further experiments to directly assess this would be needed to flesh out this possibility.

We agree with the reviewer about the limitations of using *sox10*:CreER given its additional activity outside chondrocytes (e.g. in the perichondrium). In our hands, conversion with 4OH-T at 14 dpf gave the most robust conversion in cartilage, and we have yet to find a time of 4OH-T treatment that only activates in cartilage. We also acknowledgethe limitations of our original clonal analysis given the overlapping nature of the clones. We have therefore performed new experiments using the multicolor zebrabow reporter, which operates similarly to the confetti mouse. New data in Figure 3F now more clearly support clonal contribution of chondrocytes to adipocytes and putative osteocytes.

"To more definitively follow growth plate clones, we also examined *sox10*:CreERT2; *ubb*:Zebrabow fish in which 4OH-T treatment at 14 dpf resulted in conversion of RFP (red) to various color combinations of CFP, YFP, and RFP at 23 mm SL. Analysis of uniquely colored clones in the growth plate revealed those that contained both chondrocytes and adjacent adipocytes in the marrow, as well as those that contained chondrocytes and cells embedded in cortical bone, consistent with an osteoblast/osteocyte identity (Figure 3F)."

> 3\) A major limitation of this study is that it only tracks cells but does not assess their functional contribution to mineralizaiton, for instance by deleting a gene required for mineralization using Col2a1-cre in zebrafish and observing the actual phenotypic contribution of post-chondrocyte osteoblasts to skeletal mineralization.

We agree that this would be an informative experiment in the future. Unfortunately at present, precise integration of loxP sites into the zebrafish genome is technically very challenging. To our knowledge, there is only one report to date claiming to have accomplished this (lab of David Grunwald). Even if possible, it would be a lengthy process constructing these fish, and as such we feel attempting this would be well beyond the scope of the current study.

> 4\) The investigation of cartilage cells as a source of LEPR+ cells is primarily of interest for the suggestion that cartilage is the source of the LEPR+ cell populations described in mice. However, these part of the manuscript has limitations that prevent it from providing substantial insights into the question of the source of the LEPR+ cells as they are described in the murine system.
>
> Aside from these concerns, one of the notable features of murine LEPR-cre marked cells is that LEPR generally excludes cells in the growth plate. Thus, the significance of LEPR labeling in cartilage in fish for mammalian physiology is unclear. Indeed, the labeling in cartilage appears quite weak relative to the labeling in cells adjacent to bone and it is unclear what degree of signal in this in situ hybridization based system would correspond to the cells marked by LEPR-cre in mice. There is also no characterization of the LEPR+ cells offered, so it is unclear to what degree these cells observed in zebrafish correspond functionally to murine LEPR+ cells. Additionally, a defining feature of murine LEPR osteogenic cells is that they do not emerge until adulthood. What are the kinetics of LEPR+ cells emerging during the lifetime of the fish?

In a new Figure 6---figure supplement 1, we perform *lepr* in situs at 4 additional stages in zebrafish, as well as *Lepr* in situs in mouse. These new data show conserved expression of fish/mouse *Lepr* in growth plate chondrocytes, with strongest expression in the proliferative zone. They also reveal emergence of *lepr*+ marrow cells in zebrafish only after initiation of growth plate remodeling (i.e. at 15, 20, 27 mm stages, but not at 8 and 12 mm). We discuss that this likely reflects the *Lepr*-Cre line only reporting expression of the long-isoform version of *Lepr*.

"One caveat is that we detect endogenous *lepr* expression in both marrow cells and growth plate chondrocytes in zebrafish. However, the more specific labeling of marrow cells by the *LepR*-Cre in mouse likely reflects the Cre insertion being in the long *LepR* isoform (containing exon 18b) that displays more restricted expression than the short isoform (Zhou, BO et al., 2014). Indeed, *LepR* mRNA and protein has also been reported in chondrocytes of mouse (Hoggard et al., 1997), rat, and human (Morroni et al., 2004), a finding we confirmed in the postnatal mouse femur, including the same higher expression in immature versus hypertrophic chondrocytes that we observe in zebrafish (Figure 6---figure supplement 1B)."

> LEPR does not in and of itself specify a skeletal stem cell as mentioned in the text. Rather it labels a heterogeneous population of cells (as shown in Zhou BO et al. 2014) that may include a stem cell subset, though this has yet to be directly addressed experimentally.

We have revised the text to provide a more conservative treatment of LEPR as suggested.

"In mice, *LepR* expression marks a heterogeneous population of cells in endochondral bone, including a putative postnatal skeletal stem cell population (Zhou, BO et al., 2014)... These results are consistent with *lepr*+ cells in the bone marrow deriving from growth plate chondrocytes in zebrafish, although direct evidence will be needed to determine if any of these chondrocyte-derived *lepr+* marrow cells behave as skeletal stem cells in zebrafish."

"Without a comparable long-isoform *lepr*-Cre line in zebrafish, we cannot therefore conclude whether zebrafish *lepr*+ marrow cells are comparable to those described in mouse. In the future, the generation of new Cre lines to specifically mark *lepr*+ marrow cells in zebrafish will be needed to determine whether these chondrocyte-derived marrow cells also act as stem cells for osteoblasts and adipocytes in post-embryonic fish."

> 5\) The work on MMP9 is not strongly related to the rest of the manuscript. No direct evidence is offered to show that any of the phenotypes seen with the MMP9 loss of function relate to transdifferentiation of cartilage cells.

We feel that the *mmp9* mutant data make several points of interest that relate to the manuscript. First, it establishes a similar genetic dependency of growth plate remodeling in zebrafish and mouse. Prior to our work, it was unclear whether mammalian-like growth plate remodeling operated in fish. Combined with the lineage tracing data presented, the similar *mmp9* phenotypes further support conservation. In this revision, we have also performed additional *mmp9* rescue experiments (increasing *n* from 2 to 8), which allow us to conclude that Mmp9 likely functions in chondrocytes for marrow fat production, thus providing additional supporting evidence for the conversion of chondrocytes into adipocytes (see response to reviewer 2 for caveats to this analysis in the revised Discussion).

> 6\) In Figure 6, how can it be excluded that the Brdu labeling observed is due to labeling of proliferating chondrocytes that have progressed to the hypertrophic stage by the time of visualization?

We explain in the Materials and methods that fish were treated with BrdU for 1 hour followed by immediate fixation, hence detecting only cells that are actively proliferating or have only very recently divided. Progression of chondrocytes from the proliferative to the hypertrophic stage occurs on the order of days.

[^1]: These authors contributed equally to this work.
